Balaxi Pharmaceuticals Limited (BALAXI.NS)
INR 54.63
(-0.96%)
INR 54.63
(-0.96%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 456.58 Million INR | -28.34% |
| 2022 | 591.74 Million INR | 7.25% |
| 2021 | 551.76 Million INR | 23.48% |
| 2020 | 446.82 Million INR | 403.11% |
| 2019 | 82.41 Million INR | 263.41% |
| 2018 | 22.31 Million INR | 419.1% |
| 2017 | -7.65 Million INR | -6.05% |
| 2016 | -1.72 Million INR | -973.02% |
| 2015 | -673 Thousand INR | -141.41% |
| 2014 | 1.62 Million INR | 1.99% |
| 2013 | 1.59 Million INR | 158.95% |
| 2012 | 615.36 Thousand INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 78.67 Million INR | -28.97% |
| 2023 Q4 | 110.75 Million INR | -18.13% |
| 2023 Q3 | 135.27 Million INR | 22.48% |
| 2023 Q1 | 78.32 Million INR | -37.46% |
| 2023 FY | - INR | -28.34% |
| 2023 Q2 | 110.44 Million INR | 41.01% |
| 2022 Q1 | 125.22 Million INR | -18.12% |
| 2022 FY | - INR | 7.25% |
| 2022 Q4 | 125.22 Million INR | 16.76% |
| 2022 Q3 | 107.25 Million INR | 36.95% |
| 2022 Q2 | 78.32 Million INR | -37.46% |
| 2021 Q3 | 131.58 Million INR | -7.1% |
| 2021 Q2 | 141.64 Million INR | 12.78% |
| 2021 Q4 | 152.94 Million INR | 16.24% |
| 2021 FY | - INR | 23.48% |
| 2021 Q1 | 125.59 Million INR | 25.4% |
| 2020 Q3 | 122.2 Million INR | 2.83% |
| 2020 FY | - INR | 403.11% |
| 2020 Q2 | 118.83 Million INR | 12.85% |
| 2020 Q4 | 100.15 Million INR | -18.04% |
| 2020 Q1 | 105.3 Million INR | 160.27% |
| 2019 Q4 | 40.46 Million INR | 16.87% |
| 2019 Q2 | 15.84 Million INR | 10.83% |
| 2019 Q1 | 14.29 Million INR | -3.47% |
| 2019 FY | - INR | 263.41% |
| 2019 Q3 | 34.62 Million INR | 118.5% |
| 2018 Q1 | -1.28 Million INR | 40.13% |
| 2018 FY | - INR | 419.1% |
| 2018 Q4 | 14.8 Million INR | 24.47% |
| 2018 Q3 | 11.89 Million INR | 441.87% |
| 2018 Q2 | 2.19 Million INR | 270.67% |
| 2017 Q2 | -3.45 Million INR | -424.01% |
| 2017 FY | - INR | -6.05% |
| 2017 Q4 | -2.14 Million INR | -51.68% |
| 2017 Q3 | -1.41 Million INR | 58.98% |
| 2017 Q1 | -659.16 Thousand INR | 90.02% |
| 2016 Q1 | -429.78 Thousand INR | -117.24% |
| 2016 FY | - INR | -973.02% |
| 2016 Q4 | -6.6 Million INR | -2482.06% |
| 2016 Q3 | -255.92 Thousand INR | -24.85% |
| 2016 Q2 | -204.99 Thousand INR | 52.3% |
| 2015 Q3 | -282 Thousand INR | -45.02% |
| 2015 Q2 | -194.45 Thousand INR | -281.17% |
| 2015 Q1 | -51.01 Thousand INR | -131.86% |
| 2015 FY | - INR | -141.41% |
| 2015 Q4 | -197.83 Thousand INR | 29.85% |
| 2014 Q3 | 1.23 Million INR | 0.0% |
| 2014 FY | - INR | 1.99% |
| 2014 Q4 | 160.13 Thousand INR | -87.07% |
| 2013 FY | - INR | 158.95% |
| 2012 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|